NHS UPDATE – UNITED KINGDOM
Nuheara Limited (ASX: NUH) (Company or Nuheara), transforming the way people hear by creating smart hearing solutions that are smart and affordable, is pleased to announce that the National Health Service (NHS), United Kingdom, has created a new Audiological Equipment, Services and Related Consumables framework with a “Hearable” related category and has now included Nuheara’s IQbuds BOOST within that category.
IQbuds BOOST is immediately available under the contract and will be supplied and supported under the contract via Nuheara’s UK distributor, Puretone. Puretone will now look to add IQbuds2 MAX to the contract.
Commenting on the NHS developments Nuheara CEO, Justin Miller, said, “We are delighted that the NHS UK has followed the lead of NHS Scotland and created a framework that now supports a Hearables category.”
IQbuds BOOST has successfully been placed on a new NHS UK contract, reference 2020/S 017-035930 under Lot 4 – Audiological Devices, assistive listening devices, tinnitus therapy devices and hearables. The contract is now live for a 24-month period, with the option to extend for an additional 24 months.
Managing Director and CEO Nuheara Limited
INVESTOR AND MEDIA ENQUIRIES:
Shane Murphy, FTI Consulting
Email: email@example.com Phone: + 61 420 945 291
Nuheara is a global leader in smart personal hearing devices which change people’s lives by enhancing the power to hear. Nuheara has developed proprietary and multi-functional intelligent hearing technology that augments a person’s hearing and facilitates cable free connection to smart devices. Nuheara is headquartered in Perth, Australia and was the first consumer wearables technology company to be listed on the Australian Stock Exchange (ASX).
In 2016, the Company released its revolutionary wireless earbuds, IQbuds, which allow consumers to augment their hearing according to their personal hearing preferences and connect hands free with their voice-enabled smart devices. In 2020 Nuheara released its third generation IQbuds2 MAX. Nuheara products are now sold Direct To Consumer (DTC) and in major consumer electronics retailers, professional hearing clinics, pharmacies and optical chains around the world. The Company’s mission is to tra